|
TAF8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00699999450171E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.643599999965E-06 |
| Normal-vs-Stage2 |
6.414100E-02 |
| Normal-vs-Stage3 |
5.29839505603036E-11 |
| Normal-vs-Stage4 |
2.44710000041337E-07 |
| Stage1-vs-Stage2 |
8.938000E-01 |
| Stage1-vs-Stage3 |
1.775620E-03 |
| Stage1-vs-Stage4 |
8.806300E-02 |
| Stage2-vs-Stage3 |
1.336400E-01 |
| Stage2-vs-Stage4 |
3.322200E-01 |
| Stage3-vs-Stage4 |
3.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09049999533306E-09 |
| Normal-vs-AfricanAmerican |
2.185900E-02 |
| Normal-vs-Asian |
4.642400E-01 |
| Caucasian-vs-AfricanAmerican |
1.236010E-01 |
| Caucasian-vs-Asian |
2.891800E-02 |
| AfricanAmerican-vs-Asian |
1.432170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.13060000542731E-08 |
| Normal-vs-Female |
1.33360000043048E-07 |
| Male-vs-Female |
8.825200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.981540E-03 |
| Normal-vs-Age(41-60Yrs) |
3.01140000003031E-06 |
| Normal-vs-Age(61-80Yrs) |
4.94450036470084E-10 |
| Normal-vs-Age(81-100Yrs) |
5.782000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.885800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.384000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.246000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.705900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.140400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.273800E-01 |
| Normal-vs-Grade 2 |
2.6453999999454E-06 |
| Normal-vs-Grade 3 |
1.05759999646793E-08 |
| Normal-vs-Grade 4 |
2.76899999596125E-08 |
| Grade 1-vs-Grade 2 |
3.127900E-02 |
| Grade 1-vs-Grade 3 |
3.483500E-03 |
| Grade 1-vs-Grade 4 |
7.604100E-04 |
| Grade 2-vs-Grade 3 |
2.902800E-01 |
| Grade 2-vs-Grade 4 |
7.569600E-02 |
| Grade 3-vs-Grade 4 |
2.400000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66923999999069E-05 |
| Normal-vs-ccB subtype |
5.60040003261264E-09 |
| ccA subtype-vs-ccB subtype |
2.425900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.33980000006329E-07 |
| Normal-vs-N1 |
1.021050E-01 |
| N0-vs-N1 |
8.502600E-01 |
|
|
